GlassScriptPhysician profile
Nicholas J Abbott
NPI 1124319330
$29,782.43
in general payments reported to CMS, 2019-2025
19 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $136 · 2021: $203 · 2022: $399 · 2023: $6,410 · 2024: $1,134 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,994 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,938 · Travel and Lodging: $1,814 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,993.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,938.00 |
| Travel and Lodging | $1,813.97 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14,962.93 | 2019-2020 | |
| Medtronic, INC. | $5,603.67 | 2021-2024 | Selectsecure |
| Boston Scientific Corporation | $4,843.55 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Abbott Laboratories | $3,090.57 | 2019-2024 | Aveir, Jot Dx, Ep-4 |
| Biosense Webster, INC. | $401.46 | 2019-2024 | Carto 3, Nuvision Ice Catheter |
| Impulse Dynamics (USA) INC. | $254.95 | 2022-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.86 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $135.88 | 2023-2025 | Camzyos |
| Cordis US Corp. | $51.30 | 2025 | Mynx Control Venous, Mynx Control |
| Pfizer INC. | $39.97 | 2023 | |
| Heartflow, INC. | $29.56 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $29.34 | 2024 | Arcalyst |
| Shockwave Medical, INC | $26.19 | 2025 | |
| Lilly USA, LLC | $22.30 | 2025 | Zepbound |
| Inari Medical, INC. | $22.10 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.38 | 2024 | |
| Bridgebio Pharma, INC. | $18.69 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $17.40 | 2025 | |
| Penumbra, INC. | $17.33 | 2023 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Abbott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.